By Ronda Fears
Memphis, Feb. 17 - Pfizer, Inc. sold an upsized ¥115 billion of bonds in two parts with a ¥60 billion tranche of five-year 1.2% notes priced at 99.94 to yield 1.2007% and a ¥55 billion tranche of 10-year 1.8% notes priced at 99.56 to yield 1.808%, according to a market source. The deal was boosted from ¥50 billion.
In a Securities and Exchange Commission filing, Pfizer said proceeds from the bond sale would be used for general corporate purposes.
A week ago, Pfizer forecast flat sales in 2006 amid increased competition from generic medicines. The pharmaceutical giant also is exploring various options such as the sale of its over-the-counter pharmaceuticals unit, which is estimated to be worth nearly $4 billion.
Issuer: | Pfizer, Inc.
|
Issue: | Global bonds
|
Amount: | ¥115 billion, upped from ¥50 billion
|
Pricing date: | Feb. 16
|
Settlement date: | Feb. 22
|
|
Tranche A
|
Amount: | ¥55 billion
|
Bookrunners: | Mitsubishi UFJ Securities International plc and Goldman Sachs International
|
Maturity: | Feb. 22, 2016
|
Coupon: | 1.8%
|
Price: | 99.56
|
Yield: | 1.808%
|
Spread: | 30 bps over comparable Japanese government bond
|
Price talk: | 32 bps over comparable Japanese government bond
|
Ratings: | Moody's: Aaa
|
| Standard & Poor's: AAA
|
|
Tranche B
|
Amount: | ¥60 billion
|
Bookrunners: | Mitsubishi UFJ Securities International plc and Nikko Citigroup
|
Maturity: | Feb. 22, 2011
|
Coupon: | 1.2%
|
Price: | 99.94
|
Yield: | 1.2007%
|
Spread: | 22 bps over comparable Japanese government bond
|
Price talk: | 22 bps over comparable Japanese government bond
|
Ratings: | Moody's: Aaa
|
| Standard & Poor's: AAA
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.